Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women. | Immunohematology | 2024 | 38739027 | PubTator, text mining | PubMed |
| Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene. | Transfus Med | 2024 | 38711255 | PubTator, text mining | PubMed |
| USP20 deubiquitinates and stabilizes the reticulophagy receptor RETREG1/FAM134B to drive reticulophagy. | Autophagy | 2024 | 38705724 | PubTator, text mining | PubMed |
| A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system. | Transfusion | 2024 | 38686705 | PubTator, text mining | PubMed |
| Anti-D Alloimmunization Following Rhesus-Incompatible Platelet Transfusion in a Myelodysplastic Syndrome Patient. | Cureus | 2024 | 38681415 | PubTator, text mining | PubMed |
| Association of ABO, Rh-D and Kell blood groups with transfusion transmitted infections among blood donors from the Asir Region, Saudi Arabia: A retrospective observational study. | Saudi Med J | 2024 | 38657987 | PubTator, text mining | PubMed |
| Equity in blood transfusion precision services. | Int J Equity Health | 2024 | 38637779 | PubTator, text mining | PubMed |
| Estimating the serological underrecognition of patients with weak or partial RHD variants. | Transfusion | 2024 | 38634174 | PubTator, text mining | PubMed |
| Prevalence of ABO and Rhesus (D) Blood Group and Allelic Frequency at Blood Bank of Nigist Eleni Mohammed Hospital, Ethiopia. | Biomed Res Int | 2024 | 38628500 | PubTator, text mining | PubMed |
| Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. | J Clin Invest | 2024 | 38618959 | PubTator, text mining | PubMed |
| Genetic redundancy in the naphthalene-degradation pathway of Cycloclasticus pugetii strain PS-1 enables response to varying substrate concentrations. | FEMS Microbiol Ecol | 2024 | 38614960 | PubTator, text mining | PubMed |
| [Molecular biology analysis of 2 rare RhD variant individuals with RHD*DEL37]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | 38595257 | PubTator, text mining | PubMed |
| ABO Blood Groups, RhD Factor and Their Association with Subclinical Atherosclerosis Assessed by Carotid Ultrasonography. | J Clin Med | 2024 | 38592146 | PubTator, text mining | PubMed |
| Two Cases of Anti-D Alloimmunization in D-Negative Thai Patients as a Result of the Asian-Type DEL on Transfused Red Cells. | Transfus Med Hemother | 2024 | 38584693 | PubTator, text mining | PubMed |
| Genotypic Frequency of Rh Cw Antigen in Blood Donors of Northern Pakistan. | J Coll Physicians Surg Pak | 2024 | 38576283 | PubTator, text mining | PubMed |
| Molecular dynamics of the human RhD and RhAG blood group proteins. | Front Chem | 2024 | 38566898 | PubTator, text mining | PubMed |
| Feasibility evaluation of a blood rotation system for efficient blood product utilization in remote island settings. | Vox Sang | 2024 | 38566595 | PubTator, text mining | PubMed |
Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D. | Transfusion | 2024 | 38563495 | PubTator, text mining | PubMed |
| A novel frameshift mutation in RHAG leads to Rhnull phenotype in a Chinese individual. | Transfusion | 2024 | 38562113 | PubTator, text mining | PubMed |
| Guideline No. 448: Prevention of Rh D Alloimmunization. | J Obstet Gynaecol Can | 2024 | 38553007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=17